Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4210951
Max Phase: Preclinical
Molecular Formula: C5H8N2O2
Molecular Weight: 128.13
Molecule Type: Small molecule
Associated Items:
ID: ALA4210951
Max Phase: Preclinical
Molecular Formula: C5H8N2O2
Molecular Weight: 128.13
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C=CNC(=O)NC(C)=O
Standard InChI: InChI=1S/C5H8N2O2/c1-3-6-5(9)7-4(2)8/h3H,1H2,2H3,(H2,6,7,8,9)
Standard InChI Key: SLFPOAYQUGZUGY-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 128.13 | Molecular Weight (Monoisotopic): 128.0586 | AlogP: -0.02 | #Rotatable Bonds: 1 |
Polar Surface Area: 58.20 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 11.68 | CX Basic pKa: | CX LogP: -0.65 | CX LogD: -0.65 |
Aromatic Rings: 0 | Heavy Atoms: 9 | QED Weighted: 0.52 | Np Likeness Score: -0.38 |
1. Pagadala NS, Bjorndahl TC, Joyce M, Wishart DS, Syed K, Landi A.. (2017) The compound (3-{5-[(2,5-dimethoxyphenyl)amino]-1,3,4-thiadiazolidin-2-yl}-5,8-methoxy-2H-chromen-2-one) inhibits the prion protein conversion from PrPC to PrPSc with lower IC50 in ScN2a cells., 25 (20): [PMID:28951092] [10.1016/j.bmc.2017.09.024] |
Source(1):